These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27910121)

  • 21. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retreatment of chronic hepatitis C with interferon.
    Toyoda H; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Suga T; Ohki H; Ito O
    Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
    Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K
    Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
    Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
    Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retreatment of patients with chronic hepatitis C.
    Shiffman ML
    Hepatology; 2002 Nov; 36(5 Suppl 1):S128-34. PubMed ID: 12407586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retreatment of chronic hepatitis C: who and how?
    Heathcote J
    Liver Int; 2009 Jan; 29 Suppl 1():49-56. PubMed ID: 19207966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.
    Taliani G; Gemignani G; Ferrari C; Aceti A; Bartolozzi D; Blanc PL; Capanni M; Esperti F; Forte P; Guadagnino V; Mari T; Marino N; Milani S; Pasquazzi C; Rosina F; Tacconi D; Toti M; Zignego AL; Messerini L; Stroffolini T;
    Gastroenterology; 2006 Apr; 130(4):1098-106. PubMed ID: 16618404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.
    Nishimura S; Miura H; Yamada H; Shinoda T; Kitamura S; Miura Y
    J Gastroenterol; 2002; 37(10):854-8. PubMed ID: 12424571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection.
    Gray E; O'Leary A; Kieran JA; Fogarty E; Dowling T; Norris S;
    J Viral Hepat; 2016 Sep; 23(9):677-86. PubMed ID: 26996144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature.
    Kwo PY; Badshah MB
    Curr Gastroenterol Rep; 2015 Oct; 17(10):462. PubMed ID: 26342813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retreatment of chronic hepatitis C patients non responder to a previous antiviral treatment].
    Taliani G; Biliotti E
    Recenti Prog Med; 2007 Apr; 98(4):219-24. PubMed ID: 17547358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of standard antiviral therapy retreatment following interferon treatment failure in chronic hepatitis C patients].
    Liu JP; Kang Y; Shang J; Ding GQ; Xiao EH; Wei JF; Cao Q
    Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):656-8. PubMed ID: 24160338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.
    Milella M; Antonelli G; Santantonio T; Giannelli G; Currenti M; Monno L; Turriziani O; Pastore G; Dianzani F
    Hepatogastroenterology; 1995 Jul; 42(3):201-4. PubMed ID: 7590565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retreatment options for patients with chronic hepatitis C].
    Hrstić I; Ostojić R; Vucelić B
    Acta Med Croatica; 2009 Dec; 63(5):417-22. PubMed ID: 20198901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
    Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1995 Feb; 33(2):94-8. PubMed ID: 7725763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed.
    Pol S; Sulkowski MS; Hassanein T; Gane EJ; Liu L; Mo H; Doehle B; Kanwar B; Brainard D; Subramanian GM; Symonds WT; McHutchison JG; Nahass RG; Bennett M; Jacobson IM
    Hepatology; 2015 Jul; 62(1):129-34. PubMed ID: 25847509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
    Cammà C; Craxì A
    Semin Gastrointest Dis; 2000 Apr; 11(2):115-21. PubMed ID: 10803635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of relapsers after combination therapy for chronic hepatitis C.
    Ahmed F; Jacobson IM
    Gastroenterol Clin North Am; 2004 Sep; 33(3):513-26, viii. PubMed ID: 15324941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.